IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS
申请人:Marmsater Fredrik P.
公开号:US20100144751A1
公开(公告)日:2010-06-10
Compounds of Formula (I): are receptor tyrosine inhibitors useful in the treatment of diseases mediated by class (3) and class (5) receptor tyrosine kinases. Particular compounds of this invention have also been found to be inhibitors of Pim-1.
Compounds of the formula
wherein R¹ is hydrogen or benzyl;
R² is hydrogen or methyl;
wherein Z is hydrogen or carbobenzyloxy; and Y is hydrogen or t-butoxycarbonyl, and pharmaceutically acceptable salts of those compounds wherein at least one of Y, Z, R¹ or R² is hydrogen.
These compounds are useful as anti-infective agents and immunomodulators for stimulation of host defences in patients with an increased risk of bacterial infections.